190 related articles for article (PubMed ID: 33105908)
1. Identification of Lymphatic and Hematogenous Routes of Rapidly Labeled Radioactive and Fluorescent Exosomes through Highly Sensitive Multimodal Imaging.
Jung KO; Kim YH; Chung SJ; Lee CH; Rhee S; Pratx G; Chung JK; Youn H
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105908
[TBL] [Abstract][Full Text] [Related]
2. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free
Madru R; Budassi M; Benveniste H; Lee H; Smith SD; Schlyer DJ; Vaska P; Knutsson L; Strand SE
Cancer Biother Radiopharm; 2018 Aug; 33(6):213-220. PubMed ID: 30036073
[TBL] [Abstract][Full Text] [Related]
4. (68)Ga/DOTA- and (64)Cu/NOTA-phthalocyanine conjugates as fluorescent/PET bimodal imaging probes.
Ranyuk E; Lebel R; Bérubé-Lauzière Y; Klarskov K; Lecomte R; van Lier JE; Guérin B
Bioconjug Chem; 2013 Sep; 24(9):1624-33. PubMed ID: 23978056
[TBL] [Abstract][Full Text] [Related]
5. Hybrid lymph node imaging using 64Cu-labeled mannose-conjugated human serum albumin with and without indocyanine green.
Kang CM; An GI; Choe YS
Nucl Med Commun; 2015 Oct; 36(10):1026-34. PubMed ID: 26068310
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor.
Deng H; Wang H; Wang M; Li Z; Wu Z
Mol Pharm; 2015 Aug; 12(8):3054-61. PubMed ID: 26162008
[TBL] [Abstract][Full Text] [Related]
7. Cu
Han J; Wang X; Yu M
Bioorg Med Chem Lett; 2016 Nov; 26(22):5594-5596. PubMed ID: 27780640
[TBL] [Abstract][Full Text] [Related]
8. Delivery Efficacy Differences of Intravenous and Intraperitoneal Injection of Exosomes: Perspectives from Tracking Dye Labeled and MiRNA Encapsulated Exosomes.
Zhou X; Li Z; Sun W; Yang G; Xing C; Yuan L
Curr Drug Deliv; 2020; 17(3):186-194. PubMed ID: 31969102
[TBL] [Abstract][Full Text] [Related]
9. Multi-antitumor therapy and synchronous imaging monitoring based on exosome.
Qian R; Jing B; Jiang D; Gai Y; Zhu Z; Huang X; Gao Y; Lan X; An R
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2668-2681. PubMed ID: 35091755
[TBL] [Abstract][Full Text] [Related]
10. Heptamethine cyanine based (64)Cu-PET probe PC-1001 for cancer imaging: synthesis and in vivo evaluation.
Xiao L; Zhang Y; Yue W; Xie X; Wang JP; Chordia MD; Chung LW; Pan D
Nucl Med Biol; 2013 Apr; 40(3):351-60. PubMed ID: 23375364
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
[TBL] [Abstract][Full Text] [Related]
12. Preparation of an
Al-Karmi S; Albu SA; Vito A; Janzen N; Czorny S; Banevicius L; Nanao M; Zubieta J; Capretta A; Valliant JF
Chemistry; 2017 Jan; 23(2):254-258. PubMed ID: 27768812
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.
Beaino W; Anderson CJ
J Nucl Med; 2014 Nov; 55(11):1856-63. PubMed ID: 25256059
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
16. Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots.
Chen K; Li ZB; Wang H; Cai W; Chen X
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2235-44. PubMed ID: 18566815
[TBL] [Abstract][Full Text] [Related]
17. Copper-64 Labeled PEGylated Exosomes for In Vivo Positron Emission Tomography and Enhanced Tumor Retention.
Shi S; Li T; Wen X; Wu SY; Xiong C; Zhao J; Lincha VR; Chow DS; Liu Y; Sood AK; Li C
Bioconjug Chem; 2019 Oct; 30(10):2675-2683. PubMed ID: 31560538
[TBL] [Abstract][Full Text] [Related]
18. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
[TBL] [Abstract][Full Text] [Related]
19. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
20. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
